Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic const... Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. 詳細を表示
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4...
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at the Jefferies London...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.15 | 4.23728813559 | 3.54 | 4.05 | 3.06 | 2039798 | 3.63367199 | CS |
4 | -0.66 | -15.1724137931 | 4.35 | 4.475 | 3.06 | 1742972 | 3.64457315 | CS |
12 | -0.79 | -17.6339285714 | 4.48 | 5.07 | 3.06 | 1560765 | 4.05367479 | CS |
26 | -2.79 | -43.0555555556 | 6.48 | 7.105 | 3.06 | 1900211 | 4.93091136 | CS |
52 | -6.74 | -64.6212847555 | 10.43 | 15.7 | 3.06 | 2801405 | 8.30675826 | CS |
156 | -7.32 | -66.485013624 | 11.01 | 15.7 | 3.06 | 2526706 | 9.95840106 | CS |
260 | -8.77 | -70.3852327448 | 12.46 | 15.7 | 3.06 | 2283515 | 10.38267273 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約